[BMJ] POS1129IN VITRO EVIDENCE DEMONSTRATES THAT AFIMETORAN (BMS-986256), AN EQUIPOTENT TLR7/8 DUAL ANTAGONIST, HAS STEROID-SPARING POTENTIAL IN THE CLINIC |
|
This post will be closed automatically in 2026-10-30 12:46
Reward10points
|
post
reply
points
930
10
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification
10
Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual
10
Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
10
Assessing the relationship between hypospadias risk and parental occupational exposure to potential endocrine-disrupting chemicals
10
Obstructive sleep apnoea and cardiovascular risk in atrial fibrillation: a health system-based cohort study
